Your browser doesn't support javascript.
loading
Erlotinib Versus Gemcitabine Plus Cisplatin as Neoadjuvant Treatment of Stage IIIA-N2 EGFR-Mutant Non-Small-Cell Lung Cancer (EMERGING-CTONG 1103): A Randomized Phase II Study.
Zhong, Wen-Zhao; Chen, Ke-Neng; Chen, Chun; Gu, Chun-Dong; Wang, Jun; Yang, Xue-Ning; Mao, Wei-Min; Wang, Qun; Qiao, Gui-Bin; Cheng, Ying; Xu, Lin; Wang, Chang-Li; Chen, Ming-Wei; Kang, Xiaozheng; Yan, Wanpu; Yan, Hong-Hong; Liao, Ri-Qiang; Yang, Jin-Ji; Zhang, Xu-Chao; Zhou, Qing; Wu, Yi-Long.
Afiliação
  • Zhong WZ; Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Chen KN; Peking University Cancer Hospital and Institute, Beijing, People's Republic of China.
  • Chen C; Fujian Medical University Union Hospital, Fuzhou, People's Republic of China.
  • Gu CD; First Affiliated Hospital of Dalian Medical University, Dalian, People's Republic of China.
  • Wang J; Peking University People's Hospital, Beijing, People's Republic of China.
  • Yang XN; Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Mao WM; Zhejiang Cancer Hospital, Hangzhou, People's Republic of China.
  • Wang Q; Zhongshan Hospital, Shanghai, People's Republic of China.
  • Qiao GB; Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Cheng Y; Guangzhou Liuhuaqiao Hospital, Guangzhou, People's Republic of China.
  • Xu L; Jilin Provincial Tumor Hospital, Changchun, People's Republic of China.
  • Wang CL; Jiangsu Cancer Institute and Hospital, Nanjing, People's Republic of China.
  • Chen MW; Tianjin Medical University Cancer Institute and Hospital, Tianjin, People's Republic of China.
  • Kang X; First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, People's Republic of China.
  • Yan W; Peking University Cancer Hospital and Institute, Beijing, People's Republic of China.
  • Yan HH; Peking University Cancer Hospital and Institute, Beijing, People's Republic of China.
  • Liao RQ; Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Yang JJ; Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Zhang XC; Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Zhou Q; Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
  • Wu YL; Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China.
J Clin Oncol ; 37(25): 2235-2245, 2019 09 01.
Article em En | MEDLINE | ID: mdl-31194613
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Cloridrato de Erlotinib / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma Pulmonar de Células não Pequenas / Inibidores de Proteínas Quinases / Cloridrato de Erlotinib / Neoplasias Pulmonares Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: J Clin Oncol Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos